Copinox Ewe/Calf 4 g Capsule, Hard

البلد: المملكة المتحدة

اللغة: الإنجليزية

المصدر: VMD (Veterinary Medicines Directorate)

العنصر النشط:

Copper Oxide

متاح من:

Animax Ltd

ATC رمز:

QA12CX

INN (الاسم الدولي):

Copper Oxide

الشكل الصيدلاني:

Capsule, hard

نوع الوصفة الطبية :

AVM-GSL - Authorised Veterinary Medicine – General Sales List

المجموعة العلاجية:

Cattle, Sheep

المجال العلاجي:

Mineral

الوضع إذن:

Authorized

تاريخ الترخيص:

1999-12-23

خصائص المنتج

Revised: July 2022
AN: 00089/2022
Page 1 of 5
SUMMARY OF PRODUCTS CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Copinox Ewe/Calf 4 g Capsule, Hard
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Active Substance
Each 4g capsule provides copper oxide
equivalent to 3.48g elemental copper
Excipients
E171 - Titanium dioxide 1.9% w/w
For a full list of excipients see Section 6.1
3.
PHARMACEUTICAL FORM
Capsule, hard.
Size 000 white coloured capsule
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Sheep, Cattle (calves)
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the prevention and treatment of hypocuprosis in cattle and sheep
4.3
CONTRAINDICATIONS
Do not use unless copper deficiency is known to exist or known to be a
risk.
Do not administer to pre-ruminant animals
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Caution is advised and veterinary advice should be sought before
treating housed sheep and breeds such as North Ronaldsays, Texels
and Lleyns known to be sensitive to copper poisoning.
Do not use in pre-ruminant calves, in calve under 75Kg bodyweight or
less than 2 months of age.
Revised: July 2022
AN: 00089/2022
Page 2 of 5
4.5
SPECIAL PRECAUTIONS FOR USE
i.
Special precautions for use in animals
Animals should only be dosed if copper deficiency is known to
exist or known to be a risk.
No other form of copper supplementation should be given
immediately prior to or 6 months after administration of the
capsules.
Do not exceed the recommended dose.
Care must be taken when dosing animals to avoid causing injury
to the mouth and pharynx.
ii.
Special precautions for the person administering the veterinary
medicinal product to animals
None.
iii.
Other precautions
None
4.6
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
Not to be expected provided the recommended dosage regimes are
followed.
4.7
USE DURING PREGNANCY, LACTATION OR LAY
No adverse effects known
4.8
INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
Copper reacts with many elements, the most important of which is
molybde